ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
33 hedge funds and large institutions have $26.2M invested in Orchard Therapeutics plc American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $28K
Holders
33
Holding in Top 10
–
Calls
–
Puts
$28K
Top Buyers
| 1 | +$4.56M | |
| 2 | +$674K | |
| 3 | +$355K | |
| 4 |
Renaissance Technologies
New York
|
+$178K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$148K |
Top Sellers
| 1 | -$7.38M | |
| 2 | -$870K | |
| 3 | -$769K | |
| 4 |
Temasek Holdings
Singapore
|
-$414K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$269K |